Sensus Healthcare ($SRTS (-5,97%) ) has obtained MDSAP certification for its entire SRT product range (SRT-100 & Co.). Sounds bureaucratic at first - but it's pretty relevant:
👉 One audit = approval in the USA, Canada, Brazil, Japan & Australia
👉 Means: less paperwork, faster access to new markets
👉 Could give international sales a real boost
Doesn't sound like the wildest news, but this is exactly the kind of thing that can give many small caps the next boost - simplifying processes, opening up markets, scaling sales.
Incidentally, the new TDI platform is also set to follow soon, once FDA has been approved.
